Naomi Y Ko, MD MPH AM
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Hematology & Medical Oncology

MD, Johns Hopkins University School of Medicine
MPH, Johns Hopkins University School of Public Health
AM, Harvard University

Pronouns: she/her/hers

Breast Cancer
Cancer Disparities
Health Equity

Dr. Ko is an Assistant Professor of Medicine at Boston University School of Medicine (BUSM) and a medical oncologist at Boston Medical Center (BMC) who has a lifelong passion for social justice. After college, Dr. Ko participated in Teach For America followed by volunteer service at the Berkeley Free Clinic in the Bay Area. She went on to Johns Hopkins School of Medicine and School of Public Health to complete her MD MPH with a focus on health outcomes research for vulnerable populations. After internal medicine residency at Brigham and Women's Hospital she arrived for fellowship in hematology/oncology at BUSM/BMC, which allowed Dr. Ko to conduct research in the context of caring for an underserved population within a large safety net institution. She has sought out meaningful projects that are a culmination of her passion for oncology, service to the underserved, and academic research. Her research has a translational focus that has been directed to understanding the disconnect between scientific discoveries in cancer treatment and delivery of evidence-based treatment to vulnerable, racial/ethnic minority women with breast cancer. She is actively investigating how tumor biology, poverty, communication and treatment influence breast cancer outcomes in diverse breast cancer populations.

Boston University
BU-BMC Cancer Center

Boston University
Center of Excellence in Women’s Health

Boston University
Evans Center for Interdisciplinary Biomedical Research

Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer – Core A
07/05/2019 - 05/31/2024 (PI)
Dana Farber NIH-NCI

Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
08/07/2018 - 07/31/2023 (PI)
Trustees of Boston University NIH-NCI

DFCI 17-101: Palbociclib After CDK and Endocrine Therapy (PACE): A Randomized Phase II Study…
01/02/2020 - 01/01/2023 (PI)
Dana Farber

Increasing Receipt of Guideline Concordant Survivorship Care Among Black Breast Cancer Survivors…
01/01/2020 - 12/31/2021 (PI)
Mass General Hosp Pfizer, Inc

Multiscale analysis of metabolic inflammation as a driver of breast cancer
09/09/2020 - 08/31/2021 (PI)
Trustees of Boston University, BUMC National Cancer Inst

Team-based Management of CDK 4/6 inhibitors
02/25/2020 - 06/30/2021 (PI)

Improving Cancer Equity: Community-Based Engagement and Interventions
01/03/2018 - 02/28/2021 (PI)
Mass General Hosp Kraft Center for Com

Disparities in Breast Cancer Knowledge and Treatment Adherence
01/01/2019 - 12/31/2020 (PI)
Dana Farber American Cancer Soc


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Mukand NH, Ko NY, Nabulsi NA, Hubbard CC, Chiu BC, Hoskins KF, Calip GS. The association between physical health-related quality of life, physical functioning, and risk of contralateral breast cancer among older women. Breast Cancer. 2021 Nov 19. PMID: 34797467
  2. LeClair AM, Battaglia TA, Casanova NL, Haas JS, Freund KM, Moy B, Parsons SK, Ko NY, Ross J, Ohrenberger E, Mullikin KR, Lemon SC. Assessment of patient navigation programs for breast cancer patients across the city of Boston. Support Care Cancer. 2021 Nov 12.View Related Profiles. PMID: 34767089
  3. Zhou J, Cueto J, Ko NY, Hoskins KF, Nabulsi NA, Asfaw AA, Hubbard CC, Mitra D, Calip GS, Law EH. Population-based recurrence rates among older women with HR-positive, HER2-negative early breast cancer: Clinical risk factors, frailty status, and differences by race. Breast. 2021 Oct; 59:367-375. PMID: 34419726; PMCID: PMC8379689; DOI: 10.1016/j.breast.2021.08.005;
  4. Yan CH, Coleman C, Nabulsi NA, Chiu BC, Ko NY, Hoskins K, Calip GS. Associations between frailty and cancer-specific mortality among older women with breast cancer. Breast Cancer Res Treat. 2021 Oct; 189(3):769-779. PMID: 34241741
  5. Zhou J, Sweiss K, Han J, Ko NY, Patel PR, Chiu BC, Calip GS. Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma. JAMA Netw Open. 2021 07 01; 4(7):e2118410. PMID: 34313746; PMCID: PMC8316999; DOI: 10.1001/jamanetworkopen.2021.18410;
  6. Hoskins KF, Danciu OC, Ko NY, Calip GS. Association of Race/Ethnicity and the 21-Gene Recurrence Score With Breast Cancer-Specific Mortality Among US Women. JAMA Oncol. 2021 Mar 01; 7(3):370-378. PMID: 33475714; PMCID: PMC7821091; DOI: 10.1001/jamaoncol.2020.7320;
  7. Chen K, Abbassi M, Ko NY. A Shock-Like Pain and Inability to Ambulate: Thoracic Spinal Cord Compression from Hepatocellular Carcinoma. Case Rep Oncol. 2021 Jan-Apr; 14(1):56-61. PMID: 33776682; PMCID: PMC7983535; DOI: 10.1159/000509511;
  8. Zhou J, Sweiss K, Nutescu EA, Han J, Patel PR, Ko NY, Lee TA, Chiu BC, Calip GS. Racial Disparities in Intravenous Bisphosphonate Use Among Older Patients With Multiple Myeloma Enrolled in Medicare. JCO Oncol Pract. 2021 03; 17(3):e294-e312. PMID: 33449809; PMCID: PMC8257921; DOI: 10.1200/OP.20.00479;
  9. Poulson MR, Beaulieu-Jones BR, Kenzik KM, Dechert TA, Ko NY, Sachs TE, Cassidy MR. Residential Racial Segregation and Disparities in Breast Cancer Presentation, Treatment, and Survival. Ann Surg. 2021 01 01; 273(1):3-9.View Related Profiles. PMID: 32889878
  10. Gupta VK, Dennis M, Mann E, Jacobson JO, Ko NY. Identifying Actionable Causes of Potentially Avoidable Readmissions to an Oncology Service at a Safety Net Hospital. JCO Oncol Pract. 2021 03; 17(3):e454-e460. PMID: 33290161
Showing 10 of 52 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 52 publications over 11 distinct years, with a maximum of 14 publications in 2020

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Breast Cancer
Cancer Disparities
Health Services Delivery Research
Health Equity

Available to Mentor as: (Review Mentor Role Definitions):
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Project Mentor
  • Work / Life Integration Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

FGH building, 1st floor, 820 Harrison Avenue
Boston MA 02118
Google Map

617.638.5756 (fax)

Ko's Networks
Click the "See All" links for more information and interactive visualizations
Media Mentions
Similar People
Same Department